Dementia Drugs: A Family's Fight for Autonomy

Marjorie Tingley, an 85-year-old dementia patient, became the center of a fierce debate over the use of antipsychotic medications in long-term care facilities. In December 2024, her sons were informed by Vista Grande Villa in Michigan that their mother was a safety threat, with logs detailing instances of aggression towards staff.

The facility sought permission to sedate Tingley, but her sons resisted, citing the known risks of these potent drugs, including increased mortality in dementia patients. Despite their objections, Vista Grande administrators repeatedly called 911 and sent Tingley to the emergency room, leading to a 30-day eviction notice.

Tingley passed away in January 2025. Her sons have since filed a lawsuit accusing Vista Grande of negligence, emotional distress, and wrongful eviction, alleging the ER trips were retaliatory. The facility maintains the drugs were routine and hospitalizations were due to the family's refusal of on-site treatment.

This situation underscores a broader national concern about the overprescription of antipsychotics for dementia patients. Despite federal efforts to reduce their use, a significant number of Medicare beneficiaries with dementia are believed to be inappropriately prescribed these medications, which can cause severe side effects.